BSACI Registry for Immunotherapy (BRIT): Providing safe and effective immunotherapy for allergies and urticaria-Reference-Cited by-同舟云学术

BSACI Registry for Immunotherapy (BRIT): Providing safe and effective immunotherapy for allergies and urticaria

Published:2021-08 Issue:8 Volume:51 Page:985-988
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Experimental Allergy

Author:

Khan Sujoy¹^ORCID,Krishna Mamidipudi Thirumala²³⁴,Michaelis Louise J.⁵⁶^ORCID,Dawson Tom C.⁷,Marriage Deborah⁸,Thursby‐Pelham Anna⁸,Pur Özyiğit Leyla⁹^ORCID,Jones Carla¹⁰,Regent Lynne¹¹,Erlewyn‐Lajeunesse Mich¹²^ORCID

Affiliation:

1. Immunology & Allergy Hull University Teaching Hospitals NHS TrustCastle Hill Hospital Hull UK

2. Department of Allergy and Immunology University Hospitals Birmingham NHS Foundation Trust Birmingham UK

3. Institute of Immunology and Immunotherapy Institute of Clinical Sciences University of Birmingham Birmingham UK

4. IQAS Accreditation Programme, Accreditation Unit The Royal College of Physicians London UK

5. Paediatric Immunology, Allergy & Infectious Diseases Great North Children’s Hospital Newcastle upon Tyne UK

6. Institute of Population Health Sciences Newcastle University Newcastle upon Tyne UK

7. Paediatric Department Worcestershire Acute Hospitals NHS Trust Worcester UK

8. Department of Paediatrics Bristol Royal Hospital for Children Bristol UK

9. Department of Allergy University Hospitals Leicester NHS Trust Leicester UK

10. Allergy UK Sidcup UK

11. Anaphylaxis Campaign Farnborough UK

12. Department of Paediatric Allergy University Hospital Southampton NHS Foundation Trust Southampton UK

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.13887

Reference9 articles.

1. A national audit of pollen immunotherapy for children in the United Kingdom: patient selection and programme safety

2. Practice and safety of allergen-specific immunotherapy for allergic rhinitis in the UK national health service: A report of “real world” clinical practice

3. Ethnicity‐based differences in the incident risk of allergic diseases and autoimmune disorders: A UK‐based retrospective cohort study of 4.4 million participants

4. Allergen immunotherapy: The growing role of observational and randomized trial “Real‐World Evidence”

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world evidence of allergen immunotherapy;Current Opinion in Allergy & Clinical Immunology;2024-08-30

2. Allergen immunotherapy adverse events in adults with respiratory allergies‐data from ADER: An EAACI task force report;Allergy;2024-08-22

3. RIAIT (Italian Registry of Allergen Immunotherapy): Protocol for a New Tool in a New Vision of Disease-Modifying Therapy for Allergists;Journal of Personalized Medicine;2024-08-12

4. Hot topics in allergen immunotherapy, 2023: Current status and future perspective;Allergy;2023-11-20

5. Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies—Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce;Clinical and Translational Allergy;2023-06